Market research
ZSB.F Sirona Biochem Corp
F EUR Not available
Latest close
As of 27 May 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 11M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.25
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Not available
- Industry
- Not available
- ISIN
- CA82967M1005
- Market cap
- 11M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.25
About
About Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Research context
Sirona Biochem Corp appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ZSB.F discussion.
5 years, 6 months ago
Sirona Biochem Corp is currently in a long term downtrend where the price is trading 17.3% below its 200 day moving average.
From a valuation standpoint, the stock is 38.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 813.0.
Sirona Biochem Corp's total revenue rose by inf% to $18K since the same quarter in the previous year.
Its net income has increased by 64.6% to $-676K since the same quarter in the previous year.
Finally, its free cash flow fell by 23.9% to $-745K since the same quarter in the previous year.
Based on the above factors, Sirona Biochem Corp gets an overall score of 3/5.